LIPAC Oncology Names Daniel K. Spiegelman as Independent Board Advisor
- Thursday, May 13, 2021, 7:10
- Environment
- Add a comment
MENLO PARK, Calif., May 13, 2021 /PRNewswire/ — LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced the appointment of Daniel K….
About the Author
adminasapcorp has written 41816 stories on this site.